A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
A medical condition which makes a particular drug treatment or procedure advisable in line with the Product License. Drug approvals for specific indications are controlled in most countries and jurisdictions by a licensing body, including the Food and Drug Administration (FDA) in the US and the European Medical Association (EMA) in the EU.
See also:
Food And Drug Administration (FDA)
License (product)
Placebo, Compassionate use, United States adopted name (USAN), Bias, New Drug Application (NDA), Protocol, Defined daily dose (DDD), Product pipeline, Experimental drug, Epidemiology, Orphan drugs, Cost-minimisation analysis (CMA), Disease awareness marketing, Effectiveness, Pharmaceutical Researchers and Manufacturers of America (PhRMA),